Zydus Lifesciences has received approval from WHO International Non-proprietary Names (INN) for “Usnoflast” as the recommended name for ZYIL1. The INN system aims to provide healthcare professionals with a unique and universal designated name for each pharma substance.
Jubilant's Generic Loperamide Hydrochloride Receives Approval in the U.S.
Enforcement Report - Week of January 11, 2023
Mumbai-based drug firm Glenmark NSE -0.05 % is recalling over 6.5 lakh tubes of a generic skin treatment ointment due to manufacturing issues, as per the latest Enforcement Report by the US Food and Drug Administration (USFDA).
Enforcement Report - Week of August 3, 2022
Enforcement Report - Week of April 13, 2022
Enforcement Report - Week of April 6, 2022
Jubilant Cadista's Generic Doxepin Hydrochloride Receives Approval in the U.S.
Jubilant Cadista has issued a voluntary recall of one lot of birth control pills produced under contract by Cyndea Pharma in Spain because it failed dissolution tests.
Enforcement Report - Week of September 8, 2021